Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-077564

Chief Executive Officer sold 102,225 shares at an average $20.02 ($2,046,205)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Santos da Silva Jorge · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-09 Sale : show line 1 in the form 10b5-1 −33,936 $20.01 $679,059 2,843,182 D
2026-07-10 Sale : show line 2 in the form 10b5-1 −68,289 $20.02 $1,367,146 2,774,893 D
Open-market sales · 102,225 sh · avg $20.02 · $2,046,205
Loading xslF345X06/ownership.xml…